latest news releases from the newsroom
Rockwell Medical, Inc.
Rockwell Medical Technologies, Inc. Reports Second Quarter Sales Increase of 15.5 Percent; Margins Increase Sequentially
WIXOM, Mich., Aug. 12, 2008 (PRIME NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), an innovative specialty pharma company developing renal drug therapies and essential dialysate products, reported second quarter 2008 sales of $12.2 million, an increase of 15.5% over sales of $10.5 million in the second quarter of last year. First half 2008 sales of $24.6 million increased 22.8% over the first half of 2007. Loss per share in the second quarter of 2008 was ($.08) compared to ($.04) in the second quarter of 2007. Loss per share in the first half of 2008 was ($.17) compared to a loss per share of ($.18) in the first half of 2007.
Amelot Holdings, Inc.
Amelot Holdings, Inc. Announces Completion of Barbados Refining Facility
SAINT THOMAS, Barbados, Aug. 12, 2008 (PRIME NEWSWIRE) -- Amelot Oil Barbados Ltd. a wholly owned subsidiary of Amelot Oil, Inc. is pleased to announce that the Biomatic 400, an important component of the Company's biodiesel refining facilities, has been cleared by Barbados customs and is at its new home at the Future Centre in Saint Thomas, Barbados, marking the completion of the Group's Barbados refining facility.
Foundry Networks, Inc.
Foundry Simplifies Business Operations With IBM Tivoli Integration Solution
SANTA CLARA, Calif., Aug. 12, 2008 (PRIME NEWSWIRE) -- Foundry Networks(r), Inc. (Nasdaq:FDRY), a performance and total solutions leader for end-to-end routing and switching, today announced out-of-the-box integration with IBM Tivoli Netcool software for customers using Foundry(r) switching and routing products. This integration facilitates simplified operations for Foundry customers using IBM Tivoli Netcool, thereby helping improve business efficiency.
Pain Therapeutics, Inc.
FDA Accepts REMOXY New Drug Application and Grants Priority Review
SAN MATEO, Calif. and BRISTOL, Tenn., Aug. 12, 2008 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) today announced that the New Drug Application (NDA) for REMOXY(r) was accepted and granted Priority Review by the U.S. Food and Drug Administration (FDA). The FDA typically grants Priority Review to drug candidates that have the potential to demonstrate significant improvements compared to marketed products. The FDA goal for completing review of a drug with Priority Review status is six months from the date the application was submitted. The REMOXY NDA was submitted to the FDA on June 10, 2008.
ZipForm Available to Members of New Castle County Board of REALTORS
FRASER, Mich., Aug. 12, 2008 (PRIME NEWSWIRE) -- RE FormsNet (REFN) today announced that members of the New Castle County Board of REALTORS(r) (NCCBR) in Wilmington, Delaware, will be able to purchase ZipForm(r), the real estate industry's leading brand of real estate forms software. Over 2,100 members now have their forms available in an electronic document solution that will help NCCBR's agents and brokers enhance the completion of real estate contracts.
PC Group, Inc.
Langer Reports Second Quarter 2008 Operating Results
DEER PARK, N.Y., Aug. 12, 2008 (PRIME NEWSWIRE) -- Langer, Inc. (Nasdaq:GAIT) ("Langer" or the "Company") reported a net loss from continuing operations for the three months ended June 30, 2008 of approximately $640,000 or $(.06) per share on a fully diluted basis, on revenues of approximately $14.8 million. For the comparable period in 2007, the Company experienced a net loss from continuing operations of approximately $780,000 or $(.07) per share on a fully diluted basis, on revenues of approximately $14.9 million. The principal reasons for the decrease in the net loss from continuing operations was a decrease of approximately $400,000 in operating expenses, offset by a decrease in gross profit of approximately $233,000.